Xencor, Inc. (XNCR)
29.08
-0.13
(-0.45%)
USD |
NASDAQ |
Oct 30, 16:00
30.13
+1.05
(+3.61%)
After-Hours: 17:36
Xencor Cash and Short Term Investments (Annual) : 547.73M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 547.73M |
| December 31, 2024 | 497.78M |
| December 31, 2023 | 593.72M |
| December 31, 2022 | 621.76M |
| December 31, 2021 | 333.31M |
| December 31, 2020 | 601.60M |
| December 31, 2019 | 527.08M |
| December 31, 2018 | 292.06M |
| Date | Value |
|---|---|
| December 31, 2017 | 222.43M |
| December 31, 2016 | 128.74M |
| December 31, 2015 | 96.43M |
| December 31, 2014 | 54.65M |
| December 31, 2013 | 77.98M |
| December 31, 2012 | 2.312M |
| December 31, 2011 | 14.54M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 215.46M |
| UroGen Pharma Ltd. | 121.81M |
| MeiraGTx Holdings Plc | 65.93M |
| IDEAYA Biosciences, Inc. | 639.39M |
| Iovance Biotherapeutics, Inc. | 296.98M |